

By Julie Oliver-Zhang on July 5, 2011
Category: Reglan
Tags: Congress, FDA, PLIVA v. Mensing, Reglan, Supreme Court, failure to warn, generic drugs, pre-emption, safety label
Comments: Leave a comment
Bold labels are required.
Aaron M. Levine & Associates
Suite 500,
1320 19th Street NW
Washington,
DC
20036
Phone: 202-559-0393
Toll Free: 888-564-9305
Fax: 202-833-8046
Washington Law Office
Attorneys at Aaron M. Levine & Associates, in Washington, D.C., represent clients throughout the United States and from abroad as well. The firm's nationwide  practice includes the states of Maryland, Virginia, Pennsylvania, New Jersey, New York, Massachusetts, Florida, Texas, Illinois, Washington and California, and major U.S. cities such Baltimore, Philadelphia, New York City, Boston, Houston, Dallas, Chicago, Seattle, Los Angeles and San Francisco.
© 2012 by Aaron M. Levine & Associates. All rights reserved. Disclaimer | Site Map
Privacy Policy | Legal Marketing by FindLaw, a Thomson Reuters business.